Tempest Therapeutics (TPST) Short Interest
Nasdaq • TPST • US87978U2078
As of Oct 27, 2026, ORTEX estimated 2.6% of free float sold short, 1.1 days to cover, cost to borrow 23.31%. Sign up for live short interest data.
Nasdaq • TPST • US87978U2078
As of Oct 27, 2026, ORTEX estimated 2.6% of free float sold short, 1.1 days to cover, cost to borrow 23.31%. Sign up for live short interest data.
This page tracks how heavily Tempest Therapeutics (Nasdaq:TPST) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Tempest Therapeutics (Nasdaq: TPST) has a market capitalization of $6.19M. Last close $0.40 (as of 2026-11-12); 52-week range $0.34 to $9.75. ORTEX data as of 2026-10-27: short interest was 2.64% of free float, 1.1 days to cover and the average cost to borrow was 23.31%. Sign up for live short interest data.